| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±2.3% | -0.7% | over-priced |
| 05/07/2026 | ±2.2% | -2.6% | under-priced |
| 02/23/2026 | ±1.7% | +0.5% | over-priced |
| 10/30/2025 | ±3.0% | -0.1% | over-priced |
| 08/07/2025 | ±1.4% | +0.4% | over-priced |
| 05/08/2025 | ±1.6% | -0.4% | over-priced |
| 02/21/2025 | ±1.5% | -1.0% | over-priced |
| 10/31/2024 | ±2.4% | -2.7% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.90 | $4.4B | $535M |
| Q1 FY2026 | $1.52 | $4.1B | $433M |
| Q4 FY2025 | — | $4.2B | $564M |
| Q3 FY2025 | $2.05 | $4.2B | $585M |
ECL (ECL) reports in 9 days, with the next report estimated for 11/05/2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced ECL's earnings risk. Fundamentals into the print: EPS up 3.3% year-over-year, revenue up 9.7%. QuantLogix's live 5-factor engine currently reads ECL as a buy at 75/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →